If you see anything suspicious, discard it immediately
The Japan semaglutide market was valued at USD 242.7 million as of 2025, which is further projected to be worth USD 299.2 million by the end of 2026 and also increase to USD 1,955.5 million, along with a 23.2% growth rate by the end of 2035
Each dose increase may bring a temporary return of nausea and other side effects, though usually less severe than the initial experience
Malhotra A et al., SURMOUNT-OSA, NEJM 2024 (NEJMoa2404881, PMID 38912654) : tirzepatide and obstructive sleep apnea, AHI -25,3 to 52 weeks
The FDA-approved brand formulations (Wegovy and Ozempic for semaglutide
By working closely with healthcare providers and monitoring symptoms carefully, patients can find a balance that helps manage their health effectively